Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Parkinson's Disease

Free Subscription 20.05.2024 1 Ann Neurol 1 BMC Neurol 3 J Neural Transm (Vienna) 1 J Neurol Neurosurg Psychiatry 1 JAMA 2 Lancet Neurol 3 Mov Disord 1 Nat Rev Neurol 1 Nervenarzt 2 Neurobiol Dis 4 Neurology 1 Neuroscience 1 PLoS One 1 Rev Neurol (Paris)

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. ARNALDI D, Mattioli P, Raffa S, Pardini M, et al
   Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior Disorder Due to Synucleinopathy.
   Ann Neurol. 2024 Mar 11. doi: 10.1002/ana.26902.
   PubMed         Abstract available
   
   

   
   BMC Neurol

2. DO AMARAL CMS, de Almeida SB, de Almeida RP, do Nascimento SL, et al
   Effectiveness of vestibular rehabilitation on postural balance in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials.
   BMC Neurol. 2024;24:161.
   PubMed         Abstract available
   
   

   
   J Neural Transm (Vienna)

3. PHOKAEWVARANGKUL O, Auffret M, Groppa S, Markovic V, et al
   What was first and what is next in selecting device-aided therapy in Parkinson's disease? Balancing evidence and experience.
   J Neural Transm (Vienna). 2024 May 15. doi: 10.1007/s00702-024-02782.
   PubMed         Abstract available
   
   
4. ANGELINI L, Paparella G, Cannavacciuolo A, Costa D, et al
   Clinical and kinematic characterization of parkinsonian soft signs in essential tremor.
   J Neural Transm (Vienna). 2024 May 14. doi: 10.1007/s00702-024-02784.
   PubMed         Abstract available
   
   
5. KASSUBEK J, Jost WH, Schwarz J
   Sublingual apomorphine in the treatment of Parkinson's disease.
   J Neural Transm (Vienna). 2024 May 14. doi: 10.1007/s00702-024-02777.
   PubMed         Abstract available
   
   

   
   J Neurol Neurosurg Psychiatry

6. GASCA-SALAS C, Pineda-Pardo JA, Del Alamo M, Jimenez T, et al
   Nigrostriatal blood-brain barrier opening in Parkinson's disease.
   J Neurol Neurosurg Psychiatry. 2024 May 17:jnnp-2023-332967.
   PubMed         Abstract available
   
   

   
   JAMA

7. RUBIN R
   Could GLP-1 Receptor Agonists like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions?
   JAMA. 2024 Apr 19. doi: 10.1001/jama.2024.1017.
   PubMed        
   
   

   
   Lancet Neurol

8. MCGARRY A
   Negative findings from trials with NLY01 or deferiprone for Parkinson's disease - Author's reply.
   Lancet Neurol. 2024;23:559.
   PubMed        
   
   
9. MULLER T, Mohr JD
   Negative findings from trials with NLY01 or deferiprone for Parkinson's disease.
   Lancet Neurol. 2024;23:558-559.
   PubMed        
   
   

   
   Mov Disord

10. MA JH, Dong C, Qiao HW, Barret O, et al
    Striatal and Extrastriatal Monoaminergic Disruption in Progressive Supranuclear Palsy.
    Mov Disord. 2024;39:847-854.
    PubMed         Abstract available
    
    
11. ZHANG J, Liu Y, Zhao C
    SNCA-Related Parkinson's Disease Caused by Complete Chromosome 4 Paternal Uniparental Disomy.
    Mov Disord. 2024 May 13. doi: 10.1002/mds.29823.
    PubMed        
    
    
12. VAN MIDDEN V, Simoncic U, Pirtosek Z, Kojovic M, et al
    The Effect of taVNS at 25 Hz and 100 Hz on Parkinson's Disease Gait-A Randomized Motion Sensor Study.
    Mov Disord. 2024 May 17. doi: 10.1002/mds.29826.
    PubMed         Abstract available
    
    

    
    Nat Rev Neurol

13. KIANI L
    Blood test for early Parkinson disease diagnosis.
    Nat Rev Neurol. 2024 May 14. doi: 10.1038/s41582-024-00970.
    PubMed        
    
    

    
    Nervenarzt

14. SCHERBAUM R, Tonges L
    [Multidisciplinary Complex Treatment of Parkinson's disease : Cornerstone of an individualized treatment].
    Nervenarzt. 2024 May 16. doi: 10.1007/s00115-024-01666.
    PubMed         Abstract available
    
    

    
    Neurobiol Dis

15. GULBERTI A, Schneider TR, Galindo-Leon EE, Heise M, et al
    Premotor cortical beta synchronization and the network neuromodulation of externally paced finger tapping in Parkinson's disease.
    Neurobiol Dis. 2024 May 11:106529. doi: 10.1016/j.nbd.2024.106529.
    PubMed         Abstract available
    
    
16. SHI D, Wu S, Zhuang C, Mao Y, et al
    Multimodal data fusion reveals functional and neurochemical correlates of Parkinson's disease.
    Neurobiol Dis. 2024 May 11:106527. doi: 10.1016/j.nbd.2024.106527.
    PubMed         Abstract available
    
    

    
    Neurology

17. DI LUCA DG, Perlmutter JS
    Time for Clinical Dopamine Transporter Scans in Parkinsonism?: Not DAT Yet.
    Neurology. 2024;102:e209558.
    PubMed        
    
    
18. HOY CW, Chiong W
    The Ethical Landscape of Prodromal Parkinson Disease: Considerations for Shared Decision-Making and Health Equity.
    Neurology. 2024;102:e209522.
    PubMed        
    
    
19. HASTINGS A, Cullinane P, Wrigley S, Revesz T, et al
    Neuropathologic Validation and Diagnostic Accuracy of Presynaptic Dopaminergic Imaging in the Diagnosis of Parkinsonism.
    Neurology. 2024;102:e209453.
    PubMed         Abstract available
    
    
20. REES RN, Noyce AJ, Schrag AE
    Identification of Prodromal Parkinson Disease: We May Be Able to But Should We?
    Neurology. 2024;102:e209394.
    PubMed         Abstract available
    
    

    
    Neuroscience

21. DA SILVA OLIVEIRA B, Cristina de Brito Toscano E, Katharina Sabino Abreua L, de Barros Fernandes H, et al
    Nigrostriatal inflammation is associated with nonmotor symptoms in an experimental model of prodromal Parkinson's disease.
    Neuroscience. 2024 May 13:S0306-4522(24)00205.
    PubMed         Abstract available
    
    

    
    PLoS One

22. ALTHAM C, Zhang H, Pereira E
    Machine learning for the detection and diagnosis of cognitive impairment in Parkinson's Disease: A systematic review.
    PLoS One. 2024;19:e0303644.
    PubMed         Abstract available
    
    

    
    Rev Neurol (Paris)

23. BLARD F, Erraud J, Bonnet M, Auzou N, et al
    Mindfulness in Parkinson's disease: A French national survey and a pilot intervention feasibility trial using the MBSR program (M-Park).
    Rev Neurol (Paris). 2024 May 14:S0035-3787(24)00521.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.